Characterization of genomic alterations as biomarkers of immune checkpoint inhibitor (ICI) response in metastatic urothelial carcinoma (mUC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke Medical Center, Duke University, Duke Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2922422952
